Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 5667 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 55 56 57

order ascendingorder descendingSource order ascendingorder descendingDate
Gyros Protein Technologies AB. (1/19/17). "Press Release: Gyros Protein Technologies Appoints Gerrit van den Dool to Board of Directors". Uppsala. 2017-01-19
Evotec AG. (1/19/17). "Press Release: Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)". Hamburg. 2017-01-19
Genedata AG. (1/19/17). "Press Release: Genedata Launches Data Science Services for Precision Medicine". Basel. 2017-01-19
Affimed N.V.. (1/19/17). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. 2017-01-19
Elementar UK Ltd.. (1/19/17). "Press Release: Isoprime Ltd Is Changing to Elementar UK". 2017-01-19
Qiagen N.V.. (1/19/17). "Press Release: Qiagen Announces Intention to Adjust the Conversion Ratio under Its 0.375% Senior Unsecured Convertible Notes due 2019 and Its 0.875% Senior Unsecured Convertible Notes due 2021". Venlo. 2017-01-19
SGS S.A.. (1/18/17). "Press Release: SGS Opens New Consumer Products Testing Lab in Hai Phong, Vietnam". 2017-01-18
Merck KGaA. (1/18/17). "Press Release: Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage". Darmstadt. 2017-01-18
Qiagen N.V.. (1/18/17). "Press Release: Qiagen Announces Details for Completion of approximately $250 Million Synthetic Share Repurchase". Venlo. 2017-01-18
Evotec AG. (1/17/17). "Press Release: Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics". Toronto, ON & Hamburg. 2017-01-17
ObsEva S.A.. (1/17/17). "Press Release: ObsEva Expands Leadership Team and Board of Directors with Industry Veterans". Geneva. 2017-01-17
Protagen AG. (1/17/17). "Press Release: The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma". 2017-01-17
Indivumed GmbH. (1/17/17). "Press Release: Northwell Health Partners with Indivumed to Create a Cancer Research Biobank". Hamburg. 2017-01-17
InfectoGnostics Forschungscampus Jena e. V.. (1/17/17). "Press Release: MicrobeDx Europe Founded in Jena". 2017-01-17
Mologen AG. (1/17/17). "Press Release: Convertible Bond Worth €4.99 Million Successfully Placed [Not for United States, Australia, Canada or Japan, et al.]". Berlin. 2017-01-17
Dentons. (1/13/17). "Press Release: Dentons Represents Bayer – Further Sentences in the World's Largest Trial against Drug Counterfeiters". Frankfurt a. M. & Potsdam. 2017-01-13
Eppendorf AG. (1/13/17). "Press Release: William Linton Is New Member of the Supervisory Board". Hamburg. 2017-01-13
ObsEva S.A.. (1/13/17). "Press Release: ObsEva Announces Completion of Phase 1 First-in-Women Study of OBE022 for the Treatment of Preterm Labor". Geneva. 2017-01-13
Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-13
MorphoSys AG. (1/12/17). "Press Release: MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes". Planegg. 2017-01-12
Luxendo GmbH. (1/12/17). "Press Release: Luxendo Announces Series A Extension Bringing Total Capital Raised to €8 Million". Heidelberg. 2017-01-12
Evotec AG. (1/12/17). "Press Release: Haplogen’s Novel Antiviral Target Partnered with Evotec Published in »Nature«". Vienna, Amsterdam & Hamburg. 2017-01-12
Merck KGaA. (1/12/17). "Press Release: Merck and Palantir Launch New Healthcare Acceleration Partnership". Palo Alto, CA & Darmstadt. 2017-01-12
CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. 2017-01-11
Affimed N.V.. (1/11/17). "Press Release: Affimed Provides Update on NK-Cell Immuno-Oncology Platform". Heidelberg. 2017-01-11
Merck KGaA. (1/10/17). "Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe". Darmstadt. 2017-01-10
Genedata AG. (1/10/17). "Press Release: Genedata Partners with Crescendo Biologics on Next-generation Immuno-Oncology and ADC Programs". Basel. 2017-01-10
Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf. 2017-01-10
Indivumed GmbH. (1/10/17). "Press Release: Indivumed Joins Blood Profiling Atlas in Cancer (Blood PAC)". Hamburg. 2017-01-10
Mologen AG. (1/10/17). "Press Release: Grant to Collaboration Partner for Combination Study in HIV with Lead Product Lefitolimod. Gilead Sciences, Inc. Grant for Aarhus University Hospital". Berlin. 2017-01-10
Immunic AG. (1/9/17). "Press Release: Immunic Strengthens Management Team and Supervisory Board". Planegg-Martinsried. 2017-01-09
Eternygen GmbH. (1/9/17). "Press Release: Eternygen GmbH Closes € 8.0 (US$ 8.3) Million Series A Financing led by Epidarex Capital". Berlin. 2017-01-09
Merck KGaA. (1/9/17). "Press Release: Merck and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration". Darmstadt. 2017-01-09
Evotec AG. (1/9/17). "Press Release: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy". Hamburg. 2017-01-09
Qiagen N.V.. (1/9/17). "Press Release: Qiagen Enhances Bioinformatics Portfolio with Acquisition of OmicSoft". Hilden & Germantown, MD. 2017-01-09
Roche. (1/9/17). "Press Release: FDA Grants Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Priority Review in Additional Type of Advanced Bladder cancer". Basel. 2017-01-09
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. 2017-01-09
Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. 2017-01-09
Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-09
Anokion S.A.. (1/8/17). "Press Release: Anokion Announces Exclusive Strategic Collaboration with Celgene to Develop Novel Tolerance-inducing Therapeutics for Autoimmune Diseases". Lausanne & Cambridge, MA. 2017-01-08
Noxxon Pharma N.V.. (1/6/17). "Press Release: Half-yearly Report on the Liquidity Contract with Invest Securities". Berlin. 2017-01-06
Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". 2017-01-06
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. 2017-01-05
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. 2017-01-05
HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. 2017-01-05
Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. 2017-01-05
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. 2017-01-05
MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. 2017-01-05
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. 2017-01-05
Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. 2017-01-05
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. 2017-01-05
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. 2017-01-05
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. 2017-01-04
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. 2017-01-04
AiCuris Anti-infective Cures GmbH. (1/4/17). "Press Release: AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria". Wuppertal. 2017-01-04
Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. 2017-01-04
Noxxon Pharma N.V.. (1/4/17). "Press Release: Noxxon Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion. Noxxon Continues Transition to Clinical Oncology Company". Berlin. 2017-01-04
Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. 2017-01-04
Novimmune S.A.. (1/4/17). "Press Release: Novimmune Grants Tiziana an Exclusive License to NI-1201, an anti-IL-6R Monoclonal Antibody for the Treatment of Autoimmune and Inflammatory Diseases". Geneva. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
InflaRx GmbH. (1/4/17). "Press Release: InflaRx Initiates Exploratory Phase II Trial with IFX-1, a First-in-class Anti-complement C5a Antibody, in Patients with Hidradenitis Suppurativa". Jena. 2017-01-04
Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA. 2017-01-04
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. 2017-01-03
SGS S.A.. (1/3/17). "Press Release: SGS Acquires Laboratoire LCA, Morocco". 2017-01-03
Juno Therapeutics, Inc.. (1/3/17). "Press Release: Juno Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference". Seattle, WA. 2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. 2017-01-02
Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris. 2017-01-02
next pagenext page 1 2 3 ... 55 56 57



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px

» top